High incidence of HCV in HIV-negative men who have sex with men using pre-exposure prophylaxis
- PMID: 31862485
- DOI: 10.1016/j.jhep.2019.11.022
High incidence of HCV in HIV-negative men who have sex with men using pre-exposure prophylaxis
Abstract
Background & aims: HCV has emerged as a sexually transmitted infection (STI) among HIV-positive men who have sex with men (MSM). We evaluated HCV incidence and its risk factors among HIV-negative MSM using HIV pre-exposure prophylaxis (PrEP).
Methods: Participants of the Amsterdam PrEP project were tested for HCV antibodies or HCV-RNA every 6 months. Participants used daily or event-driven PrEP and could switch regimens during follow-up. We calculated incidence rates (IRs) for overall HCV infection and separately for primary and re-infection. A univariable Bayesian exponential survival model was used to identify risk factors associated with incident HCV infection. The HCV NS5B gene fragment (709 bp) was sequenced and compared to HCV isolates from HIV-positive MSM and other risk groups (n = 419) using phylogenetic analysis.
Results: Among 350 participants contributing 653.6 person-years (PYs), we detected 15 HCV infections in 14 participants (IR = 2.30/100PY). There were 8 primary infections (IR = 1.27/100PY) and 7 re-infections (IR = 27.8/100PY). IR was 2.71/100PY in daily and 1.15/100PY in event-driven PrEP users. Factors associated with incident HCV infection were higher number of receptive condomless anal sex acts with casual partners (posterior hazard ratio [HR] 1.57 per ln increase; 95% credibility interval [CrI] 1.09-2.20), anal STI (posterior HR 2.93; 95% CrI 1.24-7.13), injecting drug use (posterior HR 4.69; 95% CrI 1.61-12.09) and sharing straws when snorting drugs (posterior HR 2.62; 95% CrI 1.09-6.02). We identified robust MSM-specific HCV clusters of subtypes 1a, 4d, 2b and 3a, which included MSM with and without HIV.
Conclusions: HIV-negative MSM using PrEP are at risk of incident HCV infection, while identified risk factors are similar to those in HIV-positive MSM. Regular HCV testing is needed, especially for those with a previous HCV infection and those reporting risk factors.
Lay summary: We report that hepatitis C virus infections are frequently acquired among HIV-negative men who have sex with men (MSM) using pre-exposure prophylaxis to prevent HIV infection. New infections occurred more frequently in those reporting receptive anal sex without using condoms, having an anal sexually transmitted infection, injecting drugs, and sharing straws when snorting drugs. The viruses found in HIV-negative men using pre-exposure prophylaxis are genetically similar to those in HIV-positive men, but not in other hepatitis C risk groups, suggesting that (sexual) transmission is occurring between HIV-positive MSM and HIV-negative MSM using pre-exposure prophylaxis.
Clinical trial number: Dutch trial registration number NTR5411.
Keywords: HIV; Hepatitis C virus; Homosexuality; Male; Men who have sex with men; Molecular epidemiology; Pre-exposure prophylaxis; Risk factors.
Copyright © 2019 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort.PLoS Med. 2024 May 8;21(5):e1004328. doi: 10.1371/journal.pmed.1004328. eCollection 2024 May. PLoS Med. 2024. PMID: 38718068 Free PMC article.
-
Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.Lancet HIV. 2019 Jul;6(7):e447-e455. doi: 10.1016/S2352-3018(19)30136-5. Epub 2019 Jun 6. Lancet HIV. 2019. PMID: 31178284
-
Hepatitis C virus infection is uncommon at baseline and during follow-up among individuals using PrEP in the Dutch national PrEP programme between 2019 and 2022.Sex Transm Infect. 2024 Jul 26;100(5):288-294. doi: 10.1136/sextrans-2024-056169. Sex Transm Infect. 2024. PMID: 38914472
-
Effects of Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection on Sexual Risk Behavior in Men Who Have Sex With Men: A Systematic Review and Meta-analysis.Clin Infect Dis. 2018 Aug 16;67(5):676-686. doi: 10.1093/cid/ciy182. Clin Infect Dis. 2018. PMID: 29509889
-
Emerging viral STIs among HIV-positive men who have sex with men: the era of hepatitis C virus and human papillomavirus.Sex Transm Infect. 2017 Aug;93(5):368-373. doi: 10.1136/sextrans-2016-052677. Epub 2016 Oct 27. Sex Transm Infect. 2017. PMID: 27789574 Review.
Cited by
-
Performance of Hepatitis C Virus (HCV) Core Antigen Assay in the Diagnosis of Recently Acquired HCV Infection among High-Risk Populations.Microbiol Spectr. 2022 Jun 29;10(3):e0034522. doi: 10.1128/spectrum.00345-22. Epub 2022 May 17. Microbiol Spectr. 2022. PMID: 35579445 Free PMC article.
-
Hepatitis C antibody prevalence and active hepatitis C infection in HIV-negative gay, bisexual, and other men who have sex with men in Barcelona and Madrid, Spain (March 2018-March 2021).IJID Reg. 2023 Jul 7;8:95-104. doi: 10.1016/j.ijregi.2023.07.001. eCollection 2023 Sep. IJID Reg. 2023. PMID: 37554356 Free PMC article.
-
Evaluating hepatitis C cascade of care surveillance system in Tuscany, Italy, through a population retrospective data-linkage study, 2015-2021.BMC Infect Dis. 2024 Mar 29;24(1):362. doi: 10.1186/s12879-024-09241-z. BMC Infect Dis. 2024. PMID: 38553731 Free PMC article.
-
Global Burden and Changing Trend of Hepatitis C Virus Infection in HIV-Positive and HIV-Negative MSM: A Systematic Review and Meta-Analysis.Front Med (Lausanne). 2021 Dec 13;8:774793. doi: 10.3389/fmed.2021.774793. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34966758 Free PMC article.
-
Evaluating interventions to reduce behaviour associated with HCV reinfection in men who have sex with men: study protocol for a non-blinded, phase 2, randomised trial.Trials. 2023 Mar 15;24(1):193. doi: 10.1186/s13063-023-07161-y. Trials. 2023. PMID: 36922871 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous